First Topical Agent for Facial Erythema of Rosacea Approved

Brimonidine topical gel 0.33% (Mirvaso, Galderma Laboratories) has been approved by the FDA for facial redness resulting from rosacea in adults aged 18 years or older In clinical testing, the alpha 2 adrenergic agonist brimonidine topical gel yielded significantly greater improvement in the facial redness of rosacea than vehicle gel, according to the company sponsor… Read More

Rosacea

About Rosacea (Acne Rosacea) Rosacea (Acne Rosacea) is an inflammatory skin disorder that affects the blood vessels and pilosebaceous units of the face, specifically the central areas; the lateral aspects of the cheeks and forehead are typically spared. Rosacea appears as a background of erythema and telangiectasias (fine blood vessels), usually with superimposed papules and… Read More